i-SENS, Inc. (KOSDAQ:099190)
18,070
+10 (0.06%)
Aug 8, 2025, 3:30 PM KST
i-SENS Revenue
i-SENS had revenue of 76.27B KRW in the quarter ending March 31, 2025, with 11.50% growth. This brings the company's revenue in the last twelve months to 299.00B, up 9.57% year-over-year. In the year 2024, i-SENS had annual revenue of 291.14B with 9.81% growth.
Revenue (ttm)
299.00B
Revenue Growth
+9.57%
P/S Ratio
1.67
Revenue / Employee
347.68M
Employees
860
Market Cap
498.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 291.14B | 26.02B | 9.81% |
Dec 31, 2023 | 265.12B | 283.13M | 0.11% |
Dec 31, 2022 | 264.84B | 31.90B | 13.70% |
Dec 31, 2021 | 232.93B | 29.23B | 14.35% |
Dec 31, 2020 | 203.71B | 13.86B | 7.30% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
Peptron | 4.30B |
PharmaResearch | 392.31B |
HLB Co., Ltd. | 74.64B |